Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Liabilities and Shareholders Equity (2016 - 2020)

Historic Liabilities and Shareholders Equity for Glucotrack (GCTK) over the last 7 years, with Q3 2020 value amounting to $11.5 million.

  • Glucotrack's Liabilities and Shareholders Equity rose 48130.29% to $11.5 million in Q3 2020 from the same period last year, while for Dec 2020 it was $37.0 million, marking a year-over-year increase of 43159.85%. This contributed to the annual value of $1.1 million for FY2019, which is 5925.93% up from last year.
  • As of Q3 2020, Glucotrack's Liabilities and Shareholders Equity stood at $11.5 million, which was up 48130.29% from $12.2 million recorded in Q2 2020.
  • In the past 5 years, Glucotrack's Liabilities and Shareholders Equity ranged from a high of $13.3 million in Q1 2020 and a low of $688186.0 during Q4 2018
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $2.5 million (2018), whereas its average is $3.9 million.
  • As far as peak fluctuations go, Glucotrack's Liabilities and Shareholders Equity crashed by 5876.48% in 2018, and later skyrocketed by 148897.04% in 2020.
  • Over the past 5 years, Glucotrack's Liabilities and Shareholders Equity (Quarter) stood at $2.5 million in 2016, then tumbled by 32.18% to $1.7 million in 2017, then plummeted by 58.76% to $688186.0 in 2018, then skyrocketed by 59.26% to $1.1 million in 2019, then skyrocketed by 946.79% to $11.5 million in 2020.
  • Its Liabilities and Shareholders Equity stands at $11.5 million for Q3 2020, versus $12.2 million for Q2 2020 and $13.3 million for Q1 2020.